{
 "context": "The following article called 'Dynavax Technologies: 1Q Earnings Snapshot' was published on 2018-05-09. The body of the article is as follows:\n    \nBERKELEY, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Tuesday reported a loss of $39 million in its first quarter.\nOn a per-share basis, the Berkeley, California-based company said it had a loss of 63 cents.\nThe results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.\nThe biopharmaceutical company posted revenue of $165,000 in the period.\nDynavax Technologies shares have decreased 11 percent since the beginning of the year. The stock has more than tripled in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on DVAX at https://www.zacks.com/ap/DVAX\n\n    The day before the article was published, the stock price of Ampco-Pittsburgh Corporation was 9.600000381469727 and the day after the article was published, the stock price of Ampco-Pittsburgh Corporation was ",
 "expected": "9.949999809265137",
 "date": "2018-05-09",
 "ticker": "AP",
 "company": "Ampco-Pittsburgh Corporation",
 "url": "https://www.cnbc.com/2018/05/09/the-associated-press-dynavax-technologies-1q-earnings-snapshot.html"
}